Nomi®

Zolmitriptan
Anti-migraine (CNS Preparations)

Indication:
Acute treatment of migraine with or without aura in adults.

Dosage & Administration:
The initial recommended dose is 2.5 mg. If symptoms persist or return within 24 hours, a second dose has been shown to be effective but should not be taken within 2 hours of the initial dose.

Preparation:
Nomi® tablet: Box containing 12 tablets in blister pack.



  • Products By Trade Name

  • Products By Generic

  • Products By Therapeutic Class

  • Herbal & Nutraceuticals

  • AgroVet & Pesticides